Related Experiment Video
Updated: Apr 15, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Superbugs causing ventilator associated pneumonia in a tertiary care hospital and the return of pre-antibiotic era!
S Qureshi, C Agrawal1, M Madan
1Department of Microbiology, Subharti Medical College, Delhi-Haridwar Bypass, Meerut - 250 005, Uttar Pradesh, India.
Abstract:
The rise in super bugs causing Ventilator-Associated Pneumonia (VAP) is a major cause of mortality and morbidity despite recent advances in management owing to the looming 'antibiotic apocalypse'. The aetiology and susceptibility pattern of the VAP isolates varies with patient population, type of intensive care unit (ICU) and is an urgent diagnostic challenge. The present study carried out for a period of one year in a tertiary care hospital, enrolled patients on mechanical ventilation (MV) for ≥48 hrs. Endotracheal aspirates (ETA) from suspected VAP patients were processed by semi quantitative method. Staphylococus aureus, members of Enterobacteriaceae were more common in early onset VAP (EOVAP), while Nonfermenting Gram negative bacilli (NFGNB) were significantly associated with late onset VAP (LOVAP). Most of the isolates were multi drug resistant (MDR) super bugs. With limited treatment options left for this crisis situation like the pre-antibiotic era; it is an alarm for rational antibiotic therapy usage and intensive education programs.
Insights
Super bugs causing Ventilator-Associated Pneumonia (VAP) pose a significant threat due to rising antimicrobial resistance. Understanding pathogen patterns is crucial for effective treatment strategies against these multi-drug resistant infections.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Microbiology
Background:
- Ventilator-Associated Pneumonia (VAP) presents a significant challenge in intensive care units (ICUs).
- The emergence of multi-drug resistant (MDR) pathogens, termed 'super bugs', exacerbates VAP's mortality and morbidity.
- The 'antibiotic apocalypse' highlights the urgent need for effective VAP management strategies.
Purpose of the Study:
- To investigate the etiological agents and antimicrobial susceptibility patterns of VAP isolates.
- To differentiate causative pathogens between early-onset VAP (EOVAP) and late-onset VAP (LOVAP).
- To inform diagnostic and therapeutic approaches for VAP in a tertiary care setting.
Main Methods:
- Prospective study conducted over one year in a tertiary care hospital.
- Inclusion criteria: patients on mechanical ventilation (MV) for ≥48 hours.
- Endotracheal aspirates (ETA) processed using a semi-quantitative method for bacterial isolation and susceptibility testing.
Main Results:
- Staphylococcus aureus and Enterobacteriaceae were common in EOVAP.
- Non-fermenting Gram-negative bacilli (NFGNB) were significantly associated with LOVAP.
- A high prevalence of multi-drug resistant (MDR) organisms was observed among VAP isolates.
Conclusions:
- Pathogen profiles and resistance patterns in VAP differ between early and late onset.
- The rise of MDR super bugs necessitates urgent diagnostic strategies and rational antibiotic therapy.
- Intensified education programs on antibiotic stewardship are crucial to combat the VAP crisis.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
09:24Optical Screening of Novel Bacteria-specific Probes on Ex Vivo Human Lung Tissue by Confocal Laser Endomicroscopy
Published on: November 29, 2017
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Mechanism of Antibiotic Resistance in MRSA
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...